Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/107753| Title: | A budget impact analysis of Spiromax compared with Turbuhaler for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regions |
| Author: | Darbà, Josep Ramírez, Gabriela García-Rivero, Juan L. Mayoralas, Sagrario Pascual, José Francisco Roger, Albert Vargas, Diego Bijedic, Adi |
| Keywords: | Administració de medicaments Asma Malalties pulmonars obstructives cròniques Tractament tèrmic Economia de la salut Administration of drugs Asthma Chronic obstructive pulmonary diseases Heat treatment Medical economics |
| Issue Date: | Sep-2016 |
| Publisher: | Dove Medical Press |
| Abstract: | To assess the economic impact of the introduction of DuoResp(®) Spiromax(®) by focusing on a potential improvement in the inhalation technique to strengthen medication adherence for the treatment of moderate to severe asthmatics in Spain and five Spanish regions including Andalusia, Catalonia, Galicia, Madrid, and Valencia. ... |
| Note: | Reproducció del document publicat a: https://doi.org/10.2147/CEOR.S111453 |
| It is part of: | Clinicoeconomics and Outcomes Research, 2016, vol. 8 , p. 435-444 |
| URI: | https://hdl.handle.net/2445/107753 |
| Related resource: | https://doi.org/10.2147/CEOR.S111453 |
| ISSN: | 1178-6981 |
| Appears in Collections: | Articles publicats en revistes (Economia) |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 668397.pdf | 270.56 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License
